NASDAQ:KTTA
Pasithea Therapeutics Corp. Stock Company Profile
$7.68
+0 (+0%)
At Close: May 10, 2024
Information
1111 Lincoln Road, Suite 500
Miami Beach FL 33139
702 514 4174
www.pasithea.com
Industry: Biotechnology
Sector: Healthcare
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
